Tag: Pharmaceutical industry updates

Merck Strikes Deal for Obesity Pill In a groundbreaking move, Merck, a leading pharmaceutical company, has recently signed a deal with Hansoh Pharma, a Chinese biotech firm, to develop and market an experimental oral obesity...

The recent news of U.S. Health and Human Services Secretary Robert F. Kennedy Jr. targeting CDC and FDA advisers has sent shockwaves through the medical community. Kennedy's plan to remove members of these advisory...

Vertex Pharmaceuticals recently achieved a significant milestone with the FDA approval of their non-opioid pain drug, Journavx. This groundbreaking development opens the door for a new era in pain management, offering hope and sparking...

**Medicare to Negotiate Prices for Obesity and Diabetes Drugs, Novartis Sues Over 340B Program**In a groundbreaking move, Medicare officials have announced plans to engage in price negotiations for two major drugs, Ozempic and Wegovy,...

Lawmakers Urge FTC to Release Report on Pharmacy Benefit Managers A bipartisan, bicameral group of lawmakers has issued a call to the U.S. Federal Trade Commission (FTC) to release an interim staff report on pharmacy...

Congressional Crackdown on PBMs After two years of intense negotiations, Congress is on the brink of finalizing a deal that will rein in pharmacy benefit managers (PBMs). According to a report by STAT, lawmakers have...